1
|
Saeed MU, Hussain N, Shahbaz A, Hameed T, Iqbal HMN, Bilal M. Bioprospecting microalgae and cyanobacteria for biopharmaceutical applications. J Basic Microbiol 2022; 62:1110-1124. [PMID: 34914840 DOI: 10.1002/jobm.202100445] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2021] [Revised: 11/19/2021] [Accepted: 11/27/2021] [Indexed: 02/05/2023]
Abstract
Microalgae and cyanobacteria have sparked a lot of interest due to their potential in various industries like biorefineries, biopharmaceuticals, food supplements, nutraceuticals, and other high-value products. Polysaccharides, vitamins, proteins, enzymes, and steroids are valuable products isolated from microalgae and cyanobacteria and potentially used in health and biomedical applications. Bioactive compounds derived from microalgae and cyanobacteria exhibit various pharmaceutical properties like antibacterial, anticancer, antiviral, antialgal, and antioxidant. From the properties listed above, the research for novel antibiotics has become particularly appropriate. In addition, the possible emergence of resistance against pathogens, as well as the potential decline in antibiotic efficacy, has prompted researchers to look for a new source of antibiotics. Microalgae and cyanobacteria have indicated a great and unexplored potential among these sources. For this reason, microalgae and cyanobacteria have been highlighted for their efficiency in different industrial sectors, as well as for their potential uses in the betterment of human and environmental health. This review gives an overview of bioactive compounds and metabolites with several biological properties isolated from microalgae and cyanobacteria for treating different animal and human diseases.
Collapse
Affiliation(s)
- Muhammad U Saeed
- Center for Applied Molecular Biology (CAMB), University of the Punjab, Lahore, Pakistan
| | - Nazim Hussain
- Center for Applied Molecular Biology (CAMB), University of the Punjab, Lahore, Pakistan
| | - Areej Shahbaz
- Center for Applied Molecular Biology (CAMB), University of the Punjab, Lahore, Pakistan
| | - Tooba Hameed
- School of Biochemistry & Biotechnology, University of the Punjab Lahore, Lahore, Pakistan
| | - Hafiz M N Iqbal
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, Mexico
| | - Muhammad Bilal
- School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, China
| |
Collapse
|
2
|
Marinaccio L, Stefanucci A, Scioli G, Della Valle A, Zengin G, Cichelli A, Mollica A. Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview. Int J Mol Sci 2022; 23:ijms23062924. [PMID: 35328340 PMCID: PMC8954713 DOI: 10.3390/ijms23062924] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Revised: 03/04/2022] [Accepted: 03/06/2022] [Indexed: 12/12/2022] Open
Abstract
Elastases are a broad group of enzymes involved in the lysis of elastin, the main component of elastic fibres. They are produced and released in the human body, mainly by neutrophils and the pancreas. The imbalance between elastase activity and its endogenous inhibitors can cause different illnesses due to their excessive activity. The main aim of this review is to provide an overview of the latest advancements on the identification, structures and mechanisms of action of peptide human neutrophil elastase inhibitors isolated from natural sources, such as plants, animals, fungi, bacteria and sponges. The discovery of new elastase inhibitors could have a great impact on the pharmaceutical development of novel drugs through the optimization of the natural lead compounds. Bacteria produce mainly cyclic peptides, while animals provide for long and linear amino acid sequences. Despite their diverse natural sources, these elastase inhibitors show remarkable IC50 values in a range from nM to μM values, thus representing an interesting starting point for the further development of potent bioactive compounds on human elastase enzymes.
Collapse
Affiliation(s)
- Lorenza Marinaccio
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (L.M.); (G.S.); (A.D.V.); (A.M.)
| | - Azzurra Stefanucci
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (L.M.); (G.S.); (A.D.V.); (A.M.)
- Correspondence: ; Tel.: +39-0871-3554906
| | - Giuseppe Scioli
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (L.M.); (G.S.); (A.D.V.); (A.M.)
| | - Alice Della Valle
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (L.M.); (G.S.); (A.D.V.); (A.M.)
| | - Gokhan Zengin
- Department of Biology, Science Faculty, Selcuk University, Konya 42130, Turkey;
| | - Angelo Cichelli
- Department of Medical, Oral and Biotechnological Sciences, “G. d’Annunzio” University Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy;
| | - Adriano Mollica
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (L.M.); (G.S.); (A.D.V.); (A.M.)
| |
Collapse
|
3
|
Favas R, Morone J, Martins R, Vasconcelos V, Lopes G. Cyanobacteria and microalgae bioactive compounds in skin-ageing: potential to restore extracellular matrix filling and overcome hyperpigmentation. J Enzyme Inhib Med Chem 2021; 36:1829-1838. [PMID: 34353202 PMCID: PMC8354154 DOI: 10.1080/14756366.2021.1960830] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
As the largest organ in human body, skin acts as a physicochemical barrier, offering protection against harmful environmental stressors, such as chemicals, pathogens, temperature and radiation. Nonetheless, skins prominence goes further, with a significant psychosocial role in an increasingly ageing population. Prompted by consumers’ concern regarding skincare, cosmetic industry has been developing new formulas capable of lessening the most visible signs of ageing, including reduction in skin density and elasticity, wrinkling and hyperpigmentation. Allied to skincare is the rising importance set on natural products, sustainably obtained from less environmental impacting methods. Cyanobacteria and microalgae are adding importance in this field, given their ability to biosynthesize secondary metabolites with anti-ageing potential. In this review, we present an overview on the potential of cyanobacteria and microalgae compounds to overcome skin-ageing, essentially by exploring their effects on the metalloproteinases collagenase, elastase, gelatinase and hyaluronidase, and in other enzymes involved in the pigmentation process.
Collapse
Affiliation(s)
- Rita Favas
- CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, Matosinhos, Portugal.,FCUP, Department of Biology, Faculty of Sciences, University of Porto, Porto, Portugal
| | - Janaína Morone
- CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, Matosinhos, Portugal.,FCUP, Department of Biology, Faculty of Sciences, University of Porto, Porto, Portugal
| | - Rosário Martins
- CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, Matosinhos, Portugal.,Health and Environment Research Centre, School of Health, Polytechnic Institute of Porto, Porto, Portugal
| | - Vitor Vasconcelos
- CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, Matosinhos, Portugal.,FCUP, Department of Biology, Faculty of Sciences, University of Porto, Porto, Portugal
| | - Graciliana Lopes
- CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, Matosinhos, Portugal
| |
Collapse
|
4
|
Ahmad S, Saleem M, Riaz N, Lee YS, Diri R, Noor A, Almasri D, Bagalagel A, Elsebai MF. The Natural Polypeptides as Significant Elastase Inhibitors. Front Pharmacol 2020; 11:688. [PMID: 32581778 PMCID: PMC7291377 DOI: 10.3389/fphar.2020.00688] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Accepted: 04/27/2020] [Indexed: 12/11/2022] Open
Abstract
Human neutrophil elastase (HNE) is a major cause of the destruction of tissues in cases of several different chronic andinflammatory diseases. Overexpression of the elastase enzyme plays a significant role in the pathogenesis of various diseases including chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, rheumatoid arthritis, the rare disease cyclic hematopoiesis (or cyclic neutropenia), infections, sepsis, cystic fibrosis, myocardial ischemia/reperfusion injury and asthma, inflammation, and atherosclerosis. Human neutrophil elastase is secreted by human neutrophils due to different stimuli. Medicine-based inhibition of the over-activation of neutrophils or production and activity of elastase have been suggested to mend inflammatory diseases. Although the development of new elastase inhibitors is an essential strategy for treating the different inflammatory diseases, it has been a challenge to specifically target the activity of elastase because of its overlapping functions with those of other serine proteases. This review article highlights the reported natural polypeptides as potential inhibitors of elastase enzyme. The mechanism of action, structural features, and activity of the polypeptides have also been correlated wherever they were available.
Collapse
Affiliation(s)
- Shabir Ahmad
- Department of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.,Department of Chemistry, Post-Graduate College, Bahawalpur, Pakistan
| | - Muhammad Saleem
- Department of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
| | - Naheed Riaz
- Department of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
| | - Yong Sup Lee
- Department of Life and Nanopharmaceutical Sciences & Medicinal Chemistry Laboratory, Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, South Korea
| | - Reem Diri
- Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Ahmad Noor
- Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Diena Almasri
- Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Alaa Bagalagel
- Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Mahmoud Fahmi Elsebai
- Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.,Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| |
Collapse
|
5
|
Junk L, Kazmaier U. Total Synthesis and Configurational Revision of Mozamide A, a Hydroxy-Brunsvicamide. J Org Chem 2019; 84:2489-2500. [DOI: 10.1021/acs.joc.8b02836] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Lukas Junk
- Organic Chemistry I, Saarland University, Campus Building C4.2, D-66123 Saarbrücken, Germany
| | - Uli Kazmaier
- Organic Chemistry I, Saarland University, Campus Building C4.2, D-66123 Saarbrücken, Germany
| |
Collapse
|
6
|
Junk L, Kazmaier U. Total Synthesis of Keramamides A and L from a Common Precursor by Late-Stage Indole Synthesis and Configurational Revision. Angew Chem Int Ed Engl 2018; 57:11432-11435. [PMID: 30019808 DOI: 10.1002/anie.201806657] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2018] [Indexed: 01/27/2023]
Abstract
The marine natural products keramamide A and L, members of the class of anabaenopeptin-type peptides, were synthesized for the first time by a convergent and flexible route. The installation of the substituted tryptophan moieties was accomplished at the very end of the synthesis on the cyclic peptides, and thus enabled the synthesis of both natural products from one common precursor. The preparation of several epimers clearly indicates that the originally proposed relative configurations of both Keramamides A and L were not correct.
Collapse
Affiliation(s)
- Lukas Junk
- Institut für Organische Chemie, Universität des Saarlandes, Campus C4.2, 66123, Saarbrücken, Germany
| | - Uli Kazmaier
- Institut für Organische Chemie, Universität des Saarlandes, Campus C4.2, 66123, Saarbrücken, Germany
| |
Collapse
|
7
|
Hochscherf J, Pietsch M, Tieu W, Kuan K, Abell AD, Gütschow M, Niefind K. Crystal structure of highly glycosylated human leukocyte elastase in complex with an S2' site binding inhibitor. Acta Crystallogr F Struct Biol Commun 2018; 74:480-489. [PMID: 30084397 PMCID: PMC6096481 DOI: 10.1107/s2053230x1800537x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2018] [Accepted: 04/05/2018] [Indexed: 11/10/2022] Open
Abstract
Glycosylated human leukocyte elastase (HLE) was crystallized and structurally analysed in complex with a 1,3-thiazolidine-2,4-dione derivative that had been identified as an HLE inhibitor in preliminary studies. In contrast to previously described HLE structures with small-molecule inhibitors, in this structure the inhibitor does not bind to the S1 and S2 substrate-recognition sites; rather, this is the first HLE structure with a synthetic inhibitor in which the S2' site is blocked that normally binds the second side chain at the C-terminal side of the scissile peptide bond in a substrate protein. The inhibitor also induces the formation of crystalline HLE dimers that block access to the active sites and that are also predicted to be stable in solution. Neither such HLE dimers nor the corresponding crystal packing have been observed in previous HLE crystal structures. This novel crystalline environment contributes to the observation that comparatively large parts of the N-glycan chains of HLE are defined by electron density. The final HLE structure contains the largest structurally defined carbohydrate trees among currently available HLE structures.
Collapse
Affiliation(s)
- Jennifer Hochscherf
- Department of Chemistry, Institute of Biochemistry, Universität zu Köln, Zülpicher Str. 47, 50674 Cologne, Germany
| | - Markus Pietsch
- Centre of Pharmacology, Medical Faculty, Universität zu Köln, Gleueler Str. 24, 50931 Cologne, Germany
| | - William Tieu
- Department of Chemistry and Centre for Nanoscale BioPhotonics (CNBP), The University of Adelaide, North Terrace, Adelaide 5005, Australia
| | - Kevin Kuan
- Department of Chemistry and Centre for Nanoscale BioPhotonics (CNBP), The University of Adelaide, North Terrace, Adelaide 5005, Australia
| | - Andrew D. Abell
- Department of Chemistry and Centre for Nanoscale BioPhotonics (CNBP), The University of Adelaide, North Terrace, Adelaide 5005, Australia
| | - Michael Gütschow
- Pharmaceutical Institute, Pharmaceutical Chemistry I, Rheinische Friedrich-Wilhelms-Universität Bonn, An der Immenburg 4, 53121 Bonn, Germany
| | - Karsten Niefind
- Department of Chemistry, Institute of Biochemistry, Universität zu Köln, Zülpicher Str. 47, 50674 Cologne, Germany
| |
Collapse
|
8
|
Junk L, Kazmaier U. Totalsynthese der Keramamide A und L aus einer gemeinsamen Vorstufe durch späte Indolsynthese und Revision ihrer Konfiguration. Angew Chem Int Ed Engl 2018. [DOI: 10.1002/ange.201806657] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Lukas Junk
- Institut für Organische Chemie; Universität des Saarlandes; Campus C4.2 66123 Saarbrücken Deutschland
| | - Uli Kazmaier
- Institut für Organische Chemie; Universität des Saarlandes; Campus C4.2 66123 Saarbrücken Deutschland
| |
Collapse
|
9
|
Thiede S, Wosniok PR, Herkommer D, Schulz-Fincke AC, Gütschow M, Menche D. Total Synthesis of Leupyrrin B1: A Potent Inhibitor of Human Leukocyte Elastase. Org Lett 2016; 18:3964-7. [DOI: 10.1021/acs.orglett.6b01724] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Sebastian Thiede
- Kekulé-Institut für
Organische Chemie und Biochemie and ‡Pharmazeutisches
Institut, Universität Bonn, D-53121 Bonn, Germany
| | - Paul R. Wosniok
- Kekulé-Institut für
Organische Chemie und Biochemie and ‡Pharmazeutisches
Institut, Universität Bonn, D-53121 Bonn, Germany
| | - Daniel Herkommer
- Kekulé-Institut für
Organische Chemie und Biochemie and ‡Pharmazeutisches
Institut, Universität Bonn, D-53121 Bonn, Germany
| | - Anna-Christina Schulz-Fincke
- Kekulé-Institut für
Organische Chemie und Biochemie and ‡Pharmazeutisches
Institut, Universität Bonn, D-53121 Bonn, Germany
| | - Michael Gütschow
- Kekulé-Institut für
Organische Chemie und Biochemie and ‡Pharmazeutisches
Institut, Universität Bonn, D-53121 Bonn, Germany
| | - Dirk Menche
- Kekulé-Institut für
Organische Chemie und Biochemie and ‡Pharmazeutisches
Institut, Universität Bonn, D-53121 Bonn, Germany
| |
Collapse
|
10
|
Steinebach C, Schulz-Fincke AC, Schnakenburg G, Gütschow M. In situ generation and trapping of thioimidates: an intermolecular tandem reaction to 4-acylimino-4H-3,1-benzothiazines. RSC Adv 2016. [DOI: 10.1039/c6ra00196c] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
The proton-catalyzed transformation of 2-thioureidobenzonitriles in the presence of acyl donors provides a convenient one-step entry to 4-acylimino-4H-3,1-benzothiazines.
Collapse
Affiliation(s)
- Christian Steinebach
- Pharmaceutical Institute
- Pharmaceutical Chemistry I
- University of Bonn
- D-53121 Bonn
- Germany
| | | | | | - Michael Gütschow
- Pharmaceutical Institute
- Pharmaceutical Chemistry I
- University of Bonn
- D-53121 Bonn
- Germany
| |
Collapse
|
11
|
Sanz M, Andreote APD, Fiore MF, Dörr FA, Pinto E. Structural Characterization of New Peptide Variants Produced by Cyanobacteria from the Brazilian Atlantic Coastal Forest Using Liquid Chromatography Coupled to Quadrupole Time-of-Flight Tandem Mass Spectrometry. Mar Drugs 2015; 13:3892-919. [PMID: 26096276 PMCID: PMC4483662 DOI: 10.3390/md13063892] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2015] [Revised: 05/14/2015] [Accepted: 05/21/2015] [Indexed: 12/25/2022] Open
Abstract
Cyanobacteria from underexplored and extreme habitats are attracting increasing attention in the search for new bioactive substances. However, cyanobacterial communities from tropical and subtropical regions are still largely unknown, especially with respect to metabolite production. Among the structurally diverse secondary metabolites produced by these organisms, peptides are by far the most frequently described structures. In this work, liquid chromatography/electrospray ionization coupled to high resolution quadrupole time-of-flight tandem mass spectrometry with positive ion detection was applied to study the peptide profile of a group of cyanobacteria isolated from the Southeastern Brazilian coastal forest. A total of 38 peptides belonging to three different families (anabaenopeptins, aeruginosins, and cyanopeptolins) were detected in the extracts. Of the 38 peptides, 37 were detected here for the first time. New structural features were proposed based on mass accuracy data and isotopic patterns derived from full scan and MS/MS spectra. Interestingly, of the 40 surveyed strains only nine were confirmed to be peptide producers; all of these strains belonged to the order Nostocales (three Nostoc sp., two Desmonostoc sp. and four Brasilonema sp.).
Collapse
Affiliation(s)
- Miriam Sanz
- Faculty of Pharmaceutical Science, University of São Paulo, Avenida Lineu Prestes 580, Bl-17-05508-900 São Paulo, SP, Brazil.
| | - Ana Paula Dini Andreote
- Center for Nuclear Energy in Agriculture, University of São Paulo, Avenida Centenário 303, 13400-970 Piracicaba, SP, Brazil.
| | - Marli Fatima Fiore
- Center for Nuclear Energy in Agriculture, University of São Paulo, Avenida Centenário 303, 13400-970 Piracicaba, SP, Brazil.
| | - Felipe Augusto Dörr
- Faculty of Pharmaceutical Science, University of São Paulo, Avenida Lineu Prestes 580, Bl-17-05508-900 São Paulo, SP, Brazil.
| | - Ernani Pinto
- Faculty of Pharmaceutical Science, University of São Paulo, Avenida Lineu Prestes 580, Bl-17-05508-900 São Paulo, SP, Brazil.
| |
Collapse
|
12
|
|
13
|
Chua KCH, Pietsch M, Zhang X, Hautmann S, Chan HY, Bruning JB, Gütschow M, Abell AD. Macrocyclic Protease Inhibitors with Reduced Peptide Character. Angew Chem Int Ed Engl 2014; 53:7828-31. [DOI: 10.1002/anie.201404301] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2014] [Indexed: 01/14/2023]
|
14
|
Muscia GC, Hautmann S, Buldain GY, Asís SE, Gütschow M. Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase. Bioorg Med Chem Lett 2014; 24:1545-9. [DOI: 10.1016/j.bmcl.2014.01.081] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2014] [Revised: 01/23/2014] [Accepted: 01/27/2014] [Indexed: 10/25/2022]
|
15
|
Mayer AMS, Rodríguez AD, Taglialatela-Scafati O, Fusetani N. Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar Drugs 2013; 11:2510-73. [PMID: 23880931 PMCID: PMC3736438 DOI: 10.3390/md11072510] [Citation(s) in RCA: 169] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2013] [Revised: 06/04/2013] [Accepted: 06/14/2013] [Indexed: 12/13/2022] Open
Abstract
The peer-reviewed marine pharmacology literature from 2009 to 2011 is presented in this review, following the format used in the 1998–2008 reviews of this series. The pharmacology of structurally-characterized compounds isolated from marine animals, algae, fungi and bacteria is discussed in a comprehensive manner. Antibacterial, antifungal, antiprotozoal, antituberculosis, and antiviral pharmacological activities were reported for 102 marine natural products. Additionally, 60 marine compounds were observed to affect the immune and nervous system as well as possess antidiabetic and anti-inflammatory effects. Finally, 68 marine metabolites were shown to interact with a variety of receptors and molecular targets, and thus will probably contribute to multiple pharmacological classes upon further mechanism of action studies. Marine pharmacology during 2009–2011 remained a global enterprise, with researchers from 35 countries, and the United States, contributing to the preclinical pharmacology of 262 marine compounds which are part of the preclinical pharmaceutical pipeline. Continued pharmacological research with marine natural products will contribute to enhance the marine pharmaceutical clinical pipeline, which in 2013 consisted of 17 marine natural products, analogs or derivatives targeting a limited number of disease categories.
Collapse
Affiliation(s)
- Alejandro M. S. Mayer
- Department of Pharmacology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, Illinois 60515, USA
- Author to whom correspondence should be addressed; E-Mail: ; Tel.: +1-630-515-6951; Fax: +1-630-971-6414
| | - Abimael D. Rodríguez
- Department of Chemistry, University of Puerto Rico, San Juan, Puerto Rico 00931, USA; E-Mail:
| | - Orazio Taglialatela-Scafati
- Department of Pharmacy, University of Naples “Federico II”, Via D. Montesano 49, I-80131 Napoli, Italy; E-Mail:
| | | |
Collapse
|
16
|
Costa M, Costa-Rodrigues J, Fernandes MH, Barros P, Vasconcelos V, Martins R. Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis. Mar Drugs 2012; 10:2181-2207. [PMID: 23170077 PMCID: PMC3497016 DOI: 10.3390/md10102181] [Citation(s) in RCA: 76] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2012] [Revised: 09/11/2012] [Accepted: 09/18/2012] [Indexed: 01/07/2023] Open
Abstract
Marine cyanobacteria have been considered a rich source of secondary metabolites with potential biotechnological applications, namely in the pharmacological field. Chemically diverse compounds were found to induce cytoxicity, anti-inflammatory and antibacterial activities. The potential of marine cyanobacteria as anticancer agents has however been the most explored and, besides cytotoxicity in tumor cell lines, several compounds have emerged as templates for the development of new anticancer drugs. The mechanisms implicated in the cytotoxicity of marine cyanobacteria compounds in tumor cell lines are still largely overlooked but several studies point to an implication in apoptosis. This association has been related to several apoptotic indicators such as cell cycle arrest, mitochondrial dysfunctions and oxidative damage, alterations in caspase cascade, alterations in specific proteins levels and alterations in the membrane sodium dynamics. In the present paper a compilation of the described marine cyanobacterial compounds with potential anticancer properties is presented and a review on the implication of apoptosis as the mechanism of cell death is discussed.
Collapse
Affiliation(s)
- Margarida Costa
- Marine and Environmental Research Center—CIIMAR/CIMAR, Porto University, Rua dos Bragas, 289, 4050-123 Porto, Portugal; (M.C.); (V.V.)
| | - João Costa-Rodrigues
- Laboratory of Pharmacology and Cellular Biocompatibility, Faculty of Dental Medicine, Porto University, Rua Dr. Manuel Pereira da Silva, 4200-393 Porto, Portugal; (J.C.-R.); (M.H.F.)
| | - Maria Helena Fernandes
- Laboratory of Pharmacology and Cellular Biocompatibility, Faculty of Dental Medicine, Porto University, Rua Dr. Manuel Pereira da Silva, 4200-393 Porto, Portugal; (J.C.-R.); (M.H.F.)
| | - Piedade Barros
- Centre of Health and Environmental Research—CISA, Superior School of Health Technology of Porto, Polytechnic Institute of Porto, Rua Valente Perfeito, 322, 4400-330 Vila Nova de Gaia, Portugal;
| | - Vitor Vasconcelos
- Marine and Environmental Research Center—CIIMAR/CIMAR, Porto University, Rua dos Bragas, 289, 4050-123 Porto, Portugal; (M.C.); (V.V.)
- Faculty of Sciences, Porto University, Rua do Campo Alegre, 4169-007 Porto, Portugal
| | - Rosário Martins
- Marine and Environmental Research Center—CIIMAR/CIMAR, Porto University, Rua dos Bragas, 289, 4050-123 Porto, Portugal; (M.C.); (V.V.)
- Centre of Health and Environmental Research—CISA, Superior School of Health Technology of Porto, Polytechnic Institute of Porto, Rua Valente Perfeito, 322, 4400-330 Vila Nova de Gaia, Portugal;
- Institute for Molecular and Cell Biology—IBMC, Porto University, Rua do Campo Alegre 823, 4150-180 Porto, Portugal
- Author to whom correspondence should be addressed; ; Tel.: +351-22-340-18-00; Fax: +351-22-339-06-08
| |
Collapse
|
17
|
Elsebai MF, Nazir M, Kehraus S, Egereva E, Ioset KN, Marcourt L, Jeannerat D, Gütschow M, Wolfender JL, König GM. Polyketide Skeletons from the Marine Alga-Derived FungusConiothyrium cereale. European J Org Chem 2012. [DOI: 10.1002/ejoc.201200700] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
18
|
Almeida C, Hemberger Y, Schmitt SM, Bouhired S, Natesan L, Kehraus S, Dimas K, Gütschow M, Bringmann G, König GM. Marilines A-C: Novel Phthalimidines from the Sponge-Derived Fungus Stachylidium sp. Chemistry 2012; 18:8827-34. [DOI: 10.1002/chem.201103278] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2011] [Revised: 03/20/2012] [Indexed: 01/12/2023]
|
19
|
Chlipala GE, Mo S, Orjala J. Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery. Curr Drug Targets 2011; 12:1654-73. [PMID: 21561419 PMCID: PMC3244969 DOI: 10.2174/138945011798109455] [Citation(s) in RCA: 92] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2010] [Accepted: 03/02/2011] [Indexed: 12/16/2022]
Abstract
Cyanobacteria are considered a promising source for new pharmaceutical lead compounds and a large number of chemically diverse and bioactive metabolites have been obtained from cyanobacteria over the last few decades. This review highlights the structural diversity of natural products from freshwater and terrestrial cyanobacteria. The review is divided into three areas: cytotoxic metabolites, protease inhibitors, and antimicrobial metabolites. The first section discusses the potent cytotoxins cryptophycin and tolytoxin. The second section covers protease inhibitors from freshwater and terrestrial cyanobacteria and is divided in five subsections according to structural class: aeruginosins, cyanopeptolins, microviridins, anabaenopeptins, and microginins. Structure activity relationships are discussed within each protease inhibitor class. The third section, antimicrobial metabolites from freshwater and terrestrial cyanobacteria, is divided by chemical class in three subsections: alkaloids, peptides and terpenoids. These examples emphasize the structural diversity and drug development potential of natural products from freshwater and terrestrial cyanobacteria.
Collapse
Affiliation(s)
- George E. Chlipala
- Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 S. Wood St., Chicago, Illinois, 60612
| | - Shunyan Mo
- Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 S. Wood St., Chicago, Illinois, 60612
| | - Jimmy Orjala
- Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 S. Wood St., Chicago, Illinois, 60612
| |
Collapse
|
20
|
Lucas SD, Costa E, Guedes RC, Moreira R. Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase. Med Res Rev 2011; 33 Suppl 1:E73-101. [PMID: 21681767 DOI: 10.1002/med.20247] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Chronic obstructive pulmonary disease (COPD) is a major increasing health problem and the World Health Organization (WHO) reports COPD as the fifth leading cause of death worldwide. COPD refers to a condition of inflammation and progressive weakening of the structure of the lung as well as irreversible narrowing of the airways. Current treatment is only palliative and no available drug halts the progression of the disease. Human neutrophil elastase (HNE) is a serine protease, which plays a major role in the COPD inflammatory process. The protease/anti-protease imbalance leads to an excess of extracellular HNE hydrolyzing elastin, the structural protein that confers elasticity to the lung tissue. Although HNE was identified as a therapeutic target for COPD more than 30 years ago, only Sivelestat (ONO-5046), an HNE inhibitor from Ono Pharmaceutical, has been approved for clinical use. Nevertheless, Sivelestat is only approved in Japan and its development in the USA was terminated in 2003. Other inhibitors in pre-clinical or phase I trials were discontinued for various reasons. Hence, there is an urgent need for low-molecular-weight synthetic elastase inhibitors and the present review discusses the recent advances on this field covering acylating agents, transition-state inhibitors, mechanism-based inhibitors, relevant natural products, and major patent disclosures.
Collapse
Affiliation(s)
- Susana D Lucas
- Research Institute for Medicines and Pharmaceutical Sciences, iMed UL, Faculty of Pharmacy, University of Lisbon, Av Prof Gama Pinto, 1649-003 Lisbon, Portugal
| | | | | | | |
Collapse
|
21
|
Abstract
INTRODUCTION Chronic obstructive pulmonary disease (COPD) constitutes a worldwide health problem. There is currently an urgent and unmet need for the development of small molecule therapeutics capable of blocking and/or reversing the progression of the disorder. Recent studies have greatly illuminated our understanding of the multiple pathogenic processes associated with COPD. Of paramount importance is the key role played by proteases, oxidative stress, apoptosis and inflammation. Insights gained from these studies have made possible the exploration of new therapeutic approaches. AREAS COVERED An overview of major developments in COPD research with emphasis on low-molecular mass neutrophil elastase inhibitors is described in this review. EXPERT OPINION Great strides have been made toward our understanding of the biochemical and cellular events associated with COPD. However, our knowledge regarding the inter-relationships among the multiple pathogenic mechanisms and their mediators involved is still limited. The problem is further compounded by the unavailability of suitable validated biomarkers for assessing the efficacy of potential therapeutic interventions. The complexity of COPD suggests that effective therapeutic interventions may require the administration of more than one agent such as a human neutrophil elastase or MMP-12 inhibitor with an anti-inflammatory agent such as a PDE4 inhibitor or a dual function agent capable of disrupting the cycle of proteolysis, apoptosis, inflammation and oxidative stress.
Collapse
Affiliation(s)
- William C Groutas
- Wichita State University, Department of Chemistry, Wichita, KS 67260, USA.
| | | | | |
Collapse
|
22
|
Elsebai MF, Kehraus S, Lindequist U, Sasse F, Shaaban S, Gütschow M, Josten M, Sahl HG, König GM. Antimicrobial phenalenone derivatives from the marine-derived fungus Coniothyrium cereale. Org Biomol Chem 2010; 9:802-8. [PMID: 21103541 DOI: 10.1039/c0ob00625d] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The marine-derived fungus Coniothyrium cereale was isolated from the green alga Enteromorpha sp. and found to produce the new phenalenone derivatives 1-7 as well as the known compounds lactone 8, (-) sclerodin (9), lamellicolic anhydride (10), (-) scleroderolide (11), and (-) sclerodione (12). The structures of these closely related compounds were established from extensive spectroscopic investigations on the basis of one and two dimensional NMR spectroscopic studies ((1)H, (13)C, COSY, NOESY, HSQC and HMBC) as well as mass spectrometric analysis (LC/MS, HREIMS and HRESIMS), UV and IR spectra. Compounds 5 and 11 showed the same antimicrobial activity toward Staphylococcus aureus SG 511 with an MIC value of 24 μM. The presence of a diketo-lactone ring as in compounds 5 and 11 was found to be essential for this activity. In agar diffusion assays with Mycobacterium phlei considerable inhibition zones were observed for compounds 2, 4 and 7. Compounds 1, 5 and 9 showed potent inhibition of human leukocyte elastase (HLE) with IC(50) values of 7.2, 13.3 and 10.9 μM, respectively.
Collapse
Affiliation(s)
- Mahmoud Fahmi Elsebai
- Institute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115, Bonn, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Elsebai MF, Kehraus S, Gütschow M, König GM. Spartinoxide, a New Enantiomer of A82775C with Inhibitory Activity toward HLE from the Marine-derived Fungus Phaeosphaeria spartinae. Nat Prod Commun 2010. [DOI: 10.1177/1934578x1000500718] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The fungus Phaeosphaeria spartinae is an endophyte of the marine alga Ceramium sp. Investigation of this marine-derived fungus led to the isolation of spartinoxide (1), which is the enantiomer of the known compound A82775C (2). Additionally, the known metabolites 4-hydroxy-3-prenyl-benzoic acid (4) and anofinic acid (5) were obtained. The structures of all compounds were established from extensive spectroscopic investigations. Compounds 1, 4 and 5 were assayed against the enzymes human leukocyte elastase (HLE), trypsin, acetylcholinesterase and cholesterolesterase. Compounds 1 and 4 showed potent inhibition of HLE with IC50 values of 1.71 ± 0.30 μg/mL (6.5 μM) and 1.67 ± 0.32 μg/mL (8.1 μM), respectively.
Collapse
Affiliation(s)
| | - Stefan Kehraus
- Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany
| | - Michael Gütschow
- Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany
| | - Gabriele M. König
- Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany
| |
Collapse
|